POSIFIT S.A.S is the industrial development operator of NANCYCLOTEP.

POSIFIT S.A.S. is a partner of Curium International for the production and quality control of the following two specialties, under AMM Curium International and manufactured within the pharmaceutical establishment of Curium International:

DOPACIS ([¹⁸F]-fluorolévodopa): a specialty used in PET imaging for neurological (Parkinson’s disease) or oncology (glioma, neuroendocrine tumors) indications.

The manufacturing of DOPACIS began in July 2013.

CISCHOLINE / FLUOROCHOLINE Curium INTERNATIONAL ([¹⁸F]-fluorométhylcholine): a specialty used in PET imaging for oncological indications (prostate cancer).

The production of CISCHOLINE / FLUOROCHOLINE CIS BIO INTERNATIONAL began in March 2016.

In the first quarter of 2020, POSIFIT S.A.S. will be a pharmaceutical establishment with access to a cyclotron for the production of Fluor 18, Carbon 11, Zirconium 89 and Copper 64 as well as a GMP production laboratory with the capacity to manufacture radiopharmaceuticals under contract for industrial companies.